Diaphragmatic Function as a Biomarker in Patients With Respiratory Diseases

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Dyspnea is among the most common symptoms in patients with respiratory diseases such as Asthma, chronic obstructive pulmonary disease (COPD), Fibrosis, and Pulmonary Hypertension. However, the pathophysiology and underlying mechanisms of dyspnea in patients with respiratory diseases are still poorly understood. Diaphragm dysfunction might be highly prevalent in patients with dyspnea and respiratory diseases. The association of diaphragm function and potential prognostic significance in patients with respiratory diseases has not yet been investigated.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• patient has one of the following lung diseases: COPD, bronchial asthma, pulmonary fibrosis, pulmonary hypertension

• is 18 years or older

• is mentally and physically able to understand the study and to follow instructions

• are legally competent

• signed declaration of consent

Locations
Other Locations
Germany
RWTH Aachen University Hospital
RECRUITING
Aachen
Contact Information
Primary
Jens Spiesshoefer, MD
jspiesshoefer@ukaachen.de
0049 2418037036
Time Frame
Start Date: 2023-07-01
Estimated Completion Date: 2025-06-30
Participants
Target number of participants: 800
Treatments
Patients with Asthma
Patients with COPD
Patients with Fibrosis
Patients with Pulmonary Hypertension
Sponsors
Leads: RWTH Aachen University

This content was sourced from clinicaltrials.gov